ManpowerGroup Inc. announced on October 28, 2026, the election of Lidia Fonseca to its Board of Directors. Her service is set to begin on November 1, 2026. This appointment increases the total number of directors on the board from twelve to thirteen.
Fonseca brings extensive experience in technology and business transformation. She previously served as Chief Digital and Technology Officer and Executive Vice President at Pfizer Inc. from January 2019 to April 2026. During her tenure at Pfizer, she led the company's enterprise AI, digital, data, and technology strategy, as well as Learning & Development and Business Process Excellence. She is credited with building Pfizer's enterprise AI program from inception and scaling it across the organization.
Currently, Fonseca serves as Senior Advisor to Pfizer's Chief Executive Officer. She also serves on the Board of Directors of Medtronic plc (NYSE: MDT). Prior to her role at Pfizer, she spent a decade in the diagnostics industry, holding the position of Senior Vice President and Chief Information Officer at both Quest Diagnostics and LabCorp. She began her career in operations and executive leadership roles at Philips Healthcare.
ManpowerGroup Chair & CEO Jonas Prising commented on the appointment, stating that Fonseca brings a rare combination of technology leadership and business transformation experience. He noted her strategic perspective and operational expertise will help the company advance its transformation strategy.
As a non-employee director, Fonseca will participate in the standard compensation arrangement for non-employee directors. This includes an annual cash retainer of $120,000 and an annual grant of deferred stock with a grant date fair value of approximately $180,000. She will receive a prorated retainer and grant for her service in 2026. The company also indicated that Fonseca will be entitled to reimbursement for travel expenses related to Board meetings and will enter into an indemnification agreement similar to those held by other outside directors.
